VIRALYTICS LIMITED (VLA.AX)
From ValueWiki
Business Description from asx.com.au: Intellectual property and investment company operating in the health care industry. In addition to the companies it invests in, Psiron has a number of active projects at various stages of development - these include treatments for dermatological conditions as well as cancer therapies. Psiron's strategy is to add shareholder value through the licensing and commercialisation of medical products.[1]
Company Analysis
You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.
The edit window has shortcut and help links if you need them.[2] Be bold!
News Feed
Leadership
- VIRALYTICS LIMITED Executive Information
- VIRALYTICS LIMITED Directors / Senior Management[1]
Prof. Darren Shafren (Director) Dr Dennis Feeney (Director) Mr Bryan Dulhunty (Executive Chairman, Finance Director)
Risks
This section needs content! Click the blue edit link (to the right) to contribute.
Research Links
- VIRALYTICS LIMITED Profile
- VIRALYTICS LIMITED Fundamentals
- VIRALYTICS LIMITED Technical Analysis
- VIRALYTICS LIMITED Contact Information[1]
- Website: http://www.psiron.com/
- Address: Level 1 , 82 Waterloo Road , NORTH RYDE , NSW, AUSTRALIA, 2113
- Phone: (02) 9889 1200
- Fax: (02) 9889 1288
- Share Registry: LINK MARKET SERVICES LIMITED LEVEL 12 , 300 QUEEN STREET , BRISBANE , QLD, AUSTRALIA, 4000
- Share Registry Phone: (02) 8280 7454
- VIRALYTICS LIMITED Message Boards
Notes
- ↑ 1.0 1.1 1.2 http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=VLA ASX.com.au
- ↑ This is a sample reference.










